scholarly journals 135: Improving cystic fibrosis (CF) patient registry timely data entry

2021 ◽  
Vol 20 ◽  
pp. S67-S68
Author(s):  
S. Schwartz ◽  
S. Pai ◽  
D. Beachler ◽  
J. Fullmer
2015 ◽  
Vol 192 (7) ◽  
pp. 836-842 ◽  
Author(s):  
Gregory S. Sawicki ◽  
Edward F. McKone ◽  
David J. Pasta ◽  
Stefanie J. Millar ◽  
Jeffrey S. Wagener ◽  
...  

2016 ◽  
Vol 15 ◽  
pp. S117
Author(s):  
M. Mei-Zahav ◽  
H. Mussaffi ◽  
O. Efrati ◽  
H. Blau ◽  
G. Livnat ◽  
...  

CHEST Journal ◽  
2010 ◽  
Vol 138 (6) ◽  
pp. 1448-1455 ◽  
Author(s):  
Justin R. Ortiz ◽  
Kathleen M. Neuzil ◽  
John C. Victor ◽  
Moira L. Aitken ◽  
Christopher H. Goss

2017 ◽  
Vol 2 (2) ◽  
pp. 192-192
Author(s):  
Mandana Rafeey ◽  
Leila R Kalankesh ◽  
Saeed Dastgiri ◽  
Leila Vahedi ◽  
Narmin Rasouli

Author(s):  
Anna Zolin ◽  
Anna Bossi ◽  
Natalia Cirilli ◽  
Nataliya Kashirskaya ◽  
Rita Padoan

Data collected in the European Cystic Fibrosis Society Patient Registry (ECFSPR) database were used to investigate whether risk factors for death in childhood and adolescents CF patients have different impact in countries of different income. In this way, it is possible to recognize where interventions could improve the quality of care and survival in these patients. We matched deceased and alive patients by age, country, year of follow-up. Multivariable logistic models were developed. In the years of this study, the ECFSPR collected information on 24,416 patients younger than 18 years: 7830 patients were from countries with low/middle income and 16,586 from countries with high income; among these the dead are 102 and 107 (p < 0.001), respectively. The use of oxygen, forced expiratory volume in one second (FEV1) below 40% and BMI standard deviation score (SDS) below −2 represent risk factors for death. However, some patients from countries with high income remain alive even if their values of FEV1% and BMI-SDS were low, and some deceased patients from countries with high income had high values of FEV1% (>60%). Evaluation of mortality in pediatric age may reflect the availability of resources for CF diagnosis and treatment in some countries.


Sign in / Sign up

Export Citation Format

Share Document